AEON Biopharma, Inc. (AEON)

AEON Biopharma Statistics

Total Valuation

AEON Biopharma has a market cap or net worth of $19.74 million. The enterprise value is $15.86 million.

Market Cap	19.74M
Enterprise Value	15.86M

Important Dates

The last earnings date was Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

AEON Biopharma has 26.31 million shares outstanding. The number of shares has increased by 1,222.46% in one year.

Current Share Class	26.31M
Shares Outstanding	26.31M
Shares Change (YoY)	+1,222.46%
Shares Change (QoQ)	+215.04%
Owned by Insiders (%)	9.77%
Owned by Institutions (%)	4.24%
Float	9.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.99

Current Ratio	0.99
Quick Ratio	0.94
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-101.93%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-932.64%
Weighted Average Cost of Capital (WACC)	6.78%
Revenue Per Employee	n/a
Profits Per Employee	-$7.51M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +30.24% in the last 52 weeks. The beta is 0.61, so AEON Biopharma's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	+30.24%
50-Day Moving Average	0.92
200-Day Moving Average	0.95
Relative Strength Index (RSI)	38.18
Average Volume (20 Days)	62,288

Short Selling Information

The latest short interest is 231,888, so 0.88% of the outstanding shares have been sold short.

Short Interest	231,888
Short Previous Month	103,230
Short % of Shares Out	0.88%
Short % of Float	2.40%
Short Ratio (days to cover)	1.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-18.29M
Pretax Income	-60.11M
Net Income	-60.11M
EBITDA	-18.21M
EBIT	-18.29M
Earnings Per Share (EPS)	-$3.15

Balance Sheet

The company has $6.24 million in cash and $2.37 million in debt, with a net cash position of $3.88 million or $0.15 per share.

Cash & Cash Equivalents	6.24M
Total Debt	2.37M
Net Cash	3.88M
Net Cash Per Share	$0.15
Equity (Book Value)	-16.75M
Book Value Per Share	-0.66
Working Capital	-44,000

Cash Flow

Operating Cash Flow	-12.04M
Capital Expenditures	n/a
Depreciation & Amortization	78,000
Net Borrowing	n/a
Free Cash Flow	-12.04M
FCF Per Share	-$0.46

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AEON Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,222.46%
Shareholder Yield	-1,222.46%
Earnings Yield	-304.58%
FCF Yield	-60.98%

Analyst Forecast

The average price target for AEON Biopharma is $6.70, which is 793.10% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.70
Price Target Difference	793.10%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 26, 2025. It was a reverse split with a ratio of 1:72.

Last Split Date	Feb 26, 2025
Split Type	Reverse
Split Ratio	1:72

Scores

Altman Z-Score	n/a
Piotroski F-Score	2